Skip to main content
Top
Published in: Rheumatology International 12/2017

01-12-2017 | Observational Research

HAQ score is an independent predictor of sustained remission in patients with rheumatoid arthritis

Authors: Kyung-Eun Lee, Sung-Eun Choi, Haimuzi Xu, Ji-Hyoun Kang, Dong-Jin Park, Shin-Seok Lee

Published in: Rheumatology International | Issue 12/2017

Login to get access

Abstract

We assessed potential predictors of sustained remission for 2 years according to the Disease Activity Score in 28 joints (DAS28)-CRP in patients with rheumatoid arthritis (RA). We obtained data for 290 RA outpatients, from July 2009 to September 2012. Sociodemographic data and answers to questionnaires were collected in face-to-face interviews. Remission was defined according to DAS28-CRP. Sustained remission was defined as meeting criteria for remission in the annual assessment for two consecutive years. Predictive factors of sustained remission according to DAS28-CRP were assessed by univariate and multivariate analyses. Of the 290 RA patients, the baseline remission level, according to DAS28-CRP, was 54.5%. During 2 years of follow-up, the sustained remission rate was 24.5%. RA patients who achieved sustained remission, according to DAS28-CRP, were younger, and had a shorter duration of symptoms, longer period of education, higher monthly income, lower Health Assessment Questionnaire (HAQ) score, lower physician global assessment, lower patient global assessment, lower patient pain assessment, and higher EQ-5D at baseline. Multivariate analyses showed that the baseline HAQ score was independently associated with sustained remission for 2 years according to DAS28-CRP (OR 0.298, 95% CI 0.115–0.770; p = 0.012). A lower HAQ score at baseline was an independent predictor of sustained remission at 2 years, according to DAS28-CRP. Thus, HAQ scores could be useful when stratifying patients according to risk for flare-ups in the clinic.
Literature
1.
go back to reference Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G, Combe B, Cutolo M, de Wit M, Dougados M, Emery P, Gibofsky A, Gomez-Reino JJ, Haraoui B, Kalden J, Keystone EC, Kvien TK, McInnes I, Martin-Mola E, Montecucco C, Schoels M, van der Heijde D, Committee TTE (2010) Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 69(4):631–637. doi:10.1136/ard.2009.123919 CrossRefPubMedPubMedCentral Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G, Combe B, Cutolo M, de Wit M, Dougados M, Emery P, Gibofsky A, Gomez-Reino JJ, Haraoui B, Kalden J, Keystone EC, Kvien TK, McInnes I, Martin-Mola E, Montecucco C, Schoels M, van der Heijde D, Committee TTE (2010) Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 69(4):631–637. doi:10.​1136/​ard.​2009.​123919 CrossRefPubMedPubMedCentral
4.
go back to reference Katchamart W, Johnson S, Lin HJ, Phumethum V, Salliot C, Bombardier C (2010) Predictors for remission in rheumatoid arthritis patients: a systematic review. Arthritis Care Res (Hoboken) 62(8):1128–1143. doi:10.1002/acr.20188 CrossRef Katchamart W, Johnson S, Lin HJ, Phumethum V, Salliot C, Bombardier C (2010) Predictors for remission in rheumatoid arthritis patients: a systematic review. Arthritis Care Res (Hoboken) 62(8):1128–1143. doi:10.​1002/​acr.​20188 CrossRef
5.
go back to reference Combe B, Logeart I, Belkacemi MC, Dadoun S, Schaeverbeke T, Daures JP, Dougados M (2015) Comparison of the long-term outcome for patients with rheumatoid arthritis with persistent moderate disease activity or disease remission during the first year after diagnosis: data from the ESPOIR cohort. Ann Rheum Dis 74(4):724–729. doi:10.1136/annrheumdis-2013-204178 CrossRefPubMed Combe B, Logeart I, Belkacemi MC, Dadoun S, Schaeverbeke T, Daures JP, Dougados M (2015) Comparison of the long-term outcome for patients with rheumatoid arthritis with persistent moderate disease activity or disease remission during the first year after diagnosis: data from the ESPOIR cohort. Ann Rheum Dis 74(4):724–729. doi:10.​1136/​annrheumdis-2013-204178 CrossRefPubMed
7.
go back to reference Lillegraven S, Prince FH, Shadick NA, Bykerk VP, Lu B, Frits ML, Iannaccone CK, Kvien TK, Haavardsholm EA, Weinblatt ME, Solomon DH (2012) Remission and radiographic outcome in rheumatoid arthritis: application of the 2011 ACR/EULAR remission criteria in an observational cohort. Ann Rheum Dis 71(5):681–686. doi:10.1136/ard.2011.154625 CrossRefPubMed Lillegraven S, Prince FH, Shadick NA, Bykerk VP, Lu B, Frits ML, Iannaccone CK, Kvien TK, Haavardsholm EA, Weinblatt ME, Solomon DH (2012) Remission and radiographic outcome in rheumatoid arthritis: application of the 2011 ACR/EULAR remission criteria in an observational cohort. Ann Rheum Dis 71(5):681–686. doi:10.​1136/​ard.​2011.​154625 CrossRefPubMed
8.
go back to reference Hamann P, Holland R, Hyrich K, Pauling JD, Shaddick G, Nightingale A, McHugh N (2017) Factors associated with sustained remission in rheumatoid arthritis in patients treated with anti-tumor necrosis factor. Arthritis Care Res (Hoboken) 69(6):783–793. doi:10.1002/acr.23016 CrossRef Hamann P, Holland R, Hyrich K, Pauling JD, Shaddick G, Nightingale A, McHugh N (2017) Factors associated with sustained remission in rheumatoid arthritis in patients treated with anti-tumor necrosis factor. Arthritis Care Res (Hoboken) 69(6):783–793. doi:10.​1002/​acr.​23016 CrossRef
9.
go back to reference Barnabe C, Homik J, Barr SG, Martin L, Maksymowych WP (2014) The effect of different remission definitions on identification of predictors of both point and sustained remission in rheumatoid arthritis treated with anti-TNF therapy. J Rheumatol 41(8):1607–1613. doi:10.3899/jrheum.131451 CrossRefPubMed Barnabe C, Homik J, Barr SG, Martin L, Maksymowych WP (2014) The effect of different remission definitions on identification of predictors of both point and sustained remission in rheumatoid arthritis treated with anti-TNF therapy. J Rheumatol 41(8):1607–1613. doi:10.​3899/​jrheum.​131451 CrossRefPubMed
10.
go back to reference Cook MJ, Diffin J, Scire CA, Lunt M, MacGregor AJ, Symmons DP, Verstappen SM (2016) Predictors and outcomes of sustained, intermittent or never achieving remission in patients with recent onset inflammatory polyarthritis: results from the Norfolk Arthritis Register. Rheumatology 55(9):1601–1609. doi:10.1093/rheumatology/kew210 CrossRefPubMedPubMedCentral Cook MJ, Diffin J, Scire CA, Lunt M, MacGregor AJ, Symmons DP, Verstappen SM (2016) Predictors and outcomes of sustained, intermittent or never achieving remission in patients with recent onset inflammatory polyarthritis: results from the Norfolk Arthritis Register. Rheumatology 55(9):1601–1609. doi:10.​1093/​rheumatology/​kew210 CrossRefPubMedPubMedCentral
11.
go back to reference Jayakumar K, Norton S, Dixey J, James D, Gough A, Williams P, Prouse P, Young A, Early Rheumatoid Arthritis S (2012) Sustained clinical remission in rheumatoid arthritis: prevalence and prognostic factors in an inception cohort of patients treated with conventional DMARDS. Rheumatology 51(1):169–175. doi:10.1093/rheumatology/ker250 CrossRefPubMed Jayakumar K, Norton S, Dixey J, James D, Gough A, Williams P, Prouse P, Young A, Early Rheumatoid Arthritis S (2012) Sustained clinical remission in rheumatoid arthritis: prevalence and prognostic factors in an inception cohort of patients treated with conventional DMARDS. Rheumatology 51(1):169–175. doi:10.​1093/​rheumatology/​ker250 CrossRefPubMed
12.
go back to reference Mohammed RH, Farahat F, Kewan HH, Bukhari MA (2015) Predictors of European League Against Rheumatism (EULAR) good response, DAS-28 remission and sustained responses to TNF-inhibitors in rheumatoid arthritis: a prospective study in refractory disease. Springerplus 4:207. doi:10.1186/s40064-015-0979-6 CrossRefPubMedPubMedCentral Mohammed RH, Farahat F, Kewan HH, Bukhari MA (2015) Predictors of European League Against Rheumatism (EULAR) good response, DAS-28 remission and sustained responses to TNF-inhibitors in rheumatoid arthritis: a prospective study in refractory disease. Springerplus 4:207. doi:10.​1186/​s40064-015-0979-6 CrossRefPubMedPubMedCentral
13.
go back to reference Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheumatol 31(3):315–324CrossRef Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheumatol 31(3):315–324CrossRef
14.
go back to reference Bae SC, Cook EF, Kim SY (1998) Psychometric evaluation of a Korean Health Assessment Questionnaire for clinical research. J Rheumatol 25(10):1975–1979PubMed Bae SC, Cook EF, Kim SY (1998) Psychometric evaluation of a Korean Health Assessment Questionnaire for clinical research. J Rheumatol 25(10):1975–1979PubMed
15.
go back to reference Kim MH, Cho YS, Uhm WS, Kim S, Bae SC (2005) Cross-cultural adaptation and validation of the Korean version of the EQ-5D in patients with rheumatic diseases. Qual Life Res 14(5):1401–1406CrossRefPubMed Kim MH, Cho YS, Uhm WS, Kim S, Bae SC (2005) Cross-cultural adaptation and validation of the Korean version of the EQ-5D in patients with rheumatic diseases. Qual Life Res 14(5):1401–1406CrossRefPubMed
16.
go back to reference Stucki G, Liang MH, Stucki S, Bruhlmann P, Michel BA (1995) A self-administered rheumatoid arthritis disease activity index (RADAI) for epidemiologic research. Psychometric properties and correlation with parameters of disease activity. Arthritis Rheumatol 38(6):795–798CrossRef Stucki G, Liang MH, Stucki S, Bruhlmann P, Michel BA (1995) A self-administered rheumatoid arthritis disease activity index (RADAI) for epidemiologic research. Psychometric properties and correlation with parameters of disease activity. Arthritis Rheumatol 38(6):795–798CrossRef
17.
go back to reference Fransen J, Welsing PMJ, De Keijzer RMH, Van Riel PLCM (2003) Disease activity scores using C-reactive protein: CRP may replace ESR in the assessment of RA disease activity. Ann Rheum Dis 62(Suppl 1):151 Fransen J, Welsing PMJ, De Keijzer RMH, Van Riel PLCM (2003) Disease activity scores using C-reactive protein: CRP may replace ESR in the assessment of RA disease activity. Ann Rheum Dis 62(Suppl 1):151
19.
go back to reference Wolfe F, Kleinheksel SM, Cathey MA, Hawley DJ, Spitz PW, Fries JF (1988) The clinical value of the Stanford Health Assessment Questionnaire Functional Disability Index in patients with rheumatoid arthritis. J Rheumatol 15(10):1480–1488PubMed Wolfe F, Kleinheksel SM, Cathey MA, Hawley DJ, Spitz PW, Fries JF (1988) The clinical value of the Stanford Health Assessment Questionnaire Functional Disability Index in patients with rheumatoid arthritis. J Rheumatol 15(10):1480–1488PubMed
20.
go back to reference Callahan LF, Bloch DA, Pincus T (1992) Identification of work disability in rheumatoid arthritis: physical, radiographic and laboratory variables do not add explanatory power to demographic and functional variables. J Clin Epidemiol 45(2):127–138CrossRefPubMed Callahan LF, Bloch DA, Pincus T (1992) Identification of work disability in rheumatoid arthritis: physical, radiographic and laboratory variables do not add explanatory power to demographic and functional variables. J Clin Epidemiol 45(2):127–138CrossRefPubMed
21.
22.
go back to reference Fleischmann R, van der Heijde D, Koenig AS, Pedersen R, Szumski A, Marshall L, Bananis E (2015) How much does Disease Activity Score in 28 joints ESR and CRP calculations underestimate disease activity compared with the Simplified Disease Activity Index? Ann Rheum Dis 74(6):1132–1137. doi:10.1136/annrheumdis-2013-204920 CrossRefPubMed Fleischmann R, van der Heijde D, Koenig AS, Pedersen R, Szumski A, Marshall L, Bananis E (2015) How much does Disease Activity Score in 28 joints ESR and CRP calculations underestimate disease activity compared with the Simplified Disease Activity Index? Ann Rheum Dis 74(6):1132–1137. doi:10.​1136/​annrheumdis-2013-204920 CrossRefPubMed
23.
go back to reference Gaujoux-Viala C, Mouterde G, Baillet A, Claudepierre P, Fautrel B, Le Loet X, Maillefert JF (2012) Evaluating disease activity in rheumatoid arthritis: which composite index is best? A systematic literature analysis of studies comparing the psychometric properties of the DAS, DAS28, SDAI and CDAI. Jt Bone Spine 79(2):149–155. doi:10.1016/j.jbspin.2011.04.008 CrossRef Gaujoux-Viala C, Mouterde G, Baillet A, Claudepierre P, Fautrel B, Le Loet X, Maillefert JF (2012) Evaluating disease activity in rheumatoid arthritis: which composite index is best? A systematic literature analysis of studies comparing the psychometric properties of the DAS, DAS28, SDAI and CDAI. Jt Bone Spine 79(2):149–155. doi:10.​1016/​j.​jbspin.​2011.​04.​008 CrossRef
24.
go back to reference Shaver TS, Anderson JD, Weidensaul DN, Shahouri SH, Busch RE, Mikuls TR, Michaud K, Wolfe F (2008) The problem of rheumatoid arthritis disease activity and remission in clinical practice. J Rheumatol 35(6):1015–1022PubMed Shaver TS, Anderson JD, Weidensaul DN, Shahouri SH, Busch RE, Mikuls TR, Michaud K, Wolfe F (2008) The problem of rheumatoid arthritis disease activity and remission in clinical practice. J Rheumatol 35(6):1015–1022PubMed
25.
go back to reference Sokka T, Hetland ML, Makinen H, Kautiainen H, Horslev-Petersen K, Luukkainen RK, Combe B, Badsha H, Drosos AA, Devlin J, Ferraccioli G, Morelli A, Hoekstra M, Majdan M, Sadkiewicz S, Belmonte M, Holmqvist AC, Choy E, Burmester GR, Tunc R, Dimic A, Nedovic J, Stankovic A, Bergman M, Toloza S, Pincus T, Questionnaires in Standard Monitoring of Patients With Rheumatoid Arthritis G (2008) Remission and rheumatoid arthritis: data on patients receiving usual care in twenty-four countries. Arthritis Rheumatol 58(9):2642–2651. doi:10.1002/art.23794 CrossRef Sokka T, Hetland ML, Makinen H, Kautiainen H, Horslev-Petersen K, Luukkainen RK, Combe B, Badsha H, Drosos AA, Devlin J, Ferraccioli G, Morelli A, Hoekstra M, Majdan M, Sadkiewicz S, Belmonte M, Holmqvist AC, Choy E, Burmester GR, Tunc R, Dimic A, Nedovic J, Stankovic A, Bergman M, Toloza S, Pincus T, Questionnaires in Standard Monitoring of Patients With Rheumatoid Arthritis G (2008) Remission and rheumatoid arthritis: data on patients receiving usual care in twenty-four countries. Arthritis Rheumatol 58(9):2642–2651. doi:10.​1002/​art.​23794 CrossRef
27.
go back to reference Kristensen LE, Kapetanovic MC, Gulfe A, Soderlin M, Saxne T, Geborek P (2008) Predictors of response to anti-TNF therapy according to ACR and EULAR criteria in patients with established RA: results from the South Swedish Arthritis Treatment Group Register. Rheumatology 47(4):495–499. doi:10.1093/rheumatology/ken002 CrossRefPubMed Kristensen LE, Kapetanovic MC, Gulfe A, Soderlin M, Saxne T, Geborek P (2008) Predictors of response to anti-TNF therapy according to ACR and EULAR criteria in patients with established RA: results from the South Swedish Arthritis Treatment Group Register. Rheumatology 47(4):495–499. doi:10.​1093/​rheumatology/​ken002 CrossRefPubMed
28.
go back to reference Castrejon I, Dougados M, Combe B, Fautrel B, Guillemin F, Pincus T (2016) Prediction of Remission in a French Early Arthritis Cohort by RAPID3 and other core data set measures, but not by the absence of rheumatoid factor, anticitrullinated protein antibodies, or radiographic erosions. J Rheumatol 43(7):1285–1291. doi:10.3899/jrheum.141586 CrossRefPubMed Castrejon I, Dougados M, Combe B, Fautrel B, Guillemin F, Pincus T (2016) Prediction of Remission in a French Early Arthritis Cohort by RAPID3 and other core data set measures, but not by the absence of rheumatoid factor, anticitrullinated protein antibodies, or radiographic erosions. J Rheumatol 43(7):1285–1291. doi:10.​3899/​jrheum.​141586 CrossRefPubMed
29.
go back to reference Molina E, Del Rincon I, Restrepo JF, Battafarano DF, Escalante A (2015) Association of socioeconomic status with treatment delays, disease activity, joint damage, and disability in rheumatoid arthritis. Arthritis Care Res (Hoboken) 67(7):940–946. doi:10.1002/acr.22542 CrossRef Molina E, Del Rincon I, Restrepo JF, Battafarano DF, Escalante A (2015) Association of socioeconomic status with treatment delays, disease activity, joint damage, and disability in rheumatoid arthritis. Arthritis Care Res (Hoboken) 67(7):940–946. doi:10.​1002/​acr.​22542 CrossRef
30.
go back to reference Thiele K, Huscher D, Bischoff S, Spathling-Mestekemper S, Backhaus M, Aringer M, Kohlmann T, Zink A, German Collaborative Arthritis C (2013) Performance of the 2011 ACR/EULAR preliminary remission criteria compared with DAS28 remission in unselected patients with rheumatoid arthritis. Ann Rheum Dis 72(7):1194–1199. doi:10.1136/annrheumdis-2012-201821 CrossRefPubMed Thiele K, Huscher D, Bischoff S, Spathling-Mestekemper S, Backhaus M, Aringer M, Kohlmann T, Zink A, German Collaborative Arthritis C (2013) Performance of the 2011 ACR/EULAR preliminary remission criteria compared with DAS28 remission in unselected patients with rheumatoid arthritis. Ann Rheum Dis 72(7):1194–1199. doi:10.​1136/​annrheumdis-2012-201821 CrossRefPubMed
31.
go back to reference de Punder YM, Fransen J, Kievit W, Houtman PM, Visser H, van de Laar MA, van Riel PL (2012) The prevalence of clinical remission in RA patients treated with anti-TNF: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry. Rheumatology 51(9):1610–1617. doi:10.1093/rheumatology/kes078 CrossRefPubMed de Punder YM, Fransen J, Kievit W, Houtman PM, Visser H, van de Laar MA, van Riel PL (2012) The prevalence of clinical remission in RA patients treated with anti-TNF: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry. Rheumatology 51(9):1610–1617. doi:10.​1093/​rheumatology/​kes078 CrossRefPubMed
32.
go back to reference Shahouri SH, Michaud K, Mikuls TR, Caplan L, Shaver TS, Anderson JD, Weidensaul DN, Busch RE, Wang S, Wolfe F (2011) Remission of rheumatoid arthritis in clinical practice: application of the American College of Rheumatology/European League Against Rheumatism 2011 remission criteria. Arthritis Rheumatol 63(11):3204–3215. doi:10.1002/art.30524 CrossRef Shahouri SH, Michaud K, Mikuls TR, Caplan L, Shaver TS, Anderson JD, Weidensaul DN, Busch RE, Wang S, Wolfe F (2011) Remission of rheumatoid arthritis in clinical practice: application of the American College of Rheumatology/European League Against Rheumatism 2011 remission criteria. Arthritis Rheumatol 63(11):3204–3215. doi:10.​1002/​art.​30524 CrossRef
Metadata
Title
HAQ score is an independent predictor of sustained remission in patients with rheumatoid arthritis
Authors
Kyung-Eun Lee
Sung-Eun Choi
Haimuzi Xu
Ji-Hyoun Kang
Dong-Jin Park
Shin-Seok Lee
Publication date
01-12-2017
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 12/2017
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-017-3833-z

Other articles of this Issue 12/2017

Rheumatology International 12/2017 Go to the issue

Acknowledgement to Referees

Acknowledgement to referees